SAN DIEGO, July 31, 2014 /PRNewswire/ -- CareFusion
(NYSE:CFN), a leading global medical technology company, today
announced the launch of its ChloraPrep® 1 mL applicator,
the newest addition to the ChloraPrep line of preoperative skin
preparation products.
ChloraPrep 1 mL provides clinicians with a preferred applicator
design and the same formulation as all other ChloraPrep applicators
but in a new 1 mL size. The new size is ideal for procedures with
an application area approximately 2.5 inches by 2.5 inches or
smaller.
"The new ChloraPrep 1 mL applicator is an excellent extension of
our ChloraPrep family of products, using the same formulation
clinicians have come to know and trust," said Jan Creidenberg, vice president and general
manager of Infection Prevention for CareFusion. "We continue to
extend our skin prep leadership through our commitment to
innovation and new product development to better meet our
customers' needs."
With its unique delivery system and winged activation design,
the 1 mL applicator is easy to use and can help promote aseptic
technique and best practices. ChloraPrep skin prep products have
been proven to be more effective than povidone-iodine at reducing
microorganisms on the skin that may cause infection.123
ChloraPrep chlorhexidine products also have a low incidence of
irritation and maintain their antimicrobial effectiveness in the
presence of blood, unlike iodine-based products.4
Clinicians interested in trying the new ChloraPrep 1 mL
applicator can visit carefusion.com/SmallButBig and fill out a form
to request a sample.
About CareFusion Corporation
CareFusion (NYSE:
CFN) is a global corporation serving the health care industry with
products and services that help hospitals measurably improve the
safety and quality of care. The company develops industry-leading
technologies including Alaris® infusion pumps and IV
sets, MaxPlus® and MaxZero™ IV connectors and
sets, Pyxis® automated dispensing and patient
identification systems, AVEA®, LTV® series
and AirLife® ventilation and respiratory
products, ChloraPrep® products, MedMined®
services for data mining surveillance, V. Mueller®
surgical instruments, and an extensive line of products that
support interventional medicine. CareFusion employs approximately
15,000 people across its global operations. More information may be
found at www.carefusion.com.
1 Saltzman MD, Nuber GW, Gryzlo SM, Marecek GS, Koh
JL. Efficacy of surgical preparation solutions in shoulder surgery.
J Bone Joint Surg Am. 2009;91(8):1949–1953.
2 Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical
preparation solutions in foot and ankle surgery. J Bone Joint Surg
Am. 2005;87(5):980–985.
3 Adler MT, Brigger KR, Bishop KD, Mastrobattista JM.
Comparison of bactericidal properties of alcohol-based
chlorhexidine versus povidone-iodine prior to amniocentesis. Am J
Perinatol. 2012;29(6):455–458. Epub 2012 Mar
7.
4 Denton, G. Chlorhexidine. In Block, SS. Disinfection,
Sterilization, and Preservation, 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins;
2001:321–336.
Logo -
http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO
SOURCE CareFusion